ES2114931T3 - Nuevos esteres esteroidales. - Google Patents

Nuevos esteres esteroidales.

Info

Publication number
ES2114931T3
ES2114931T3 ES92904423T ES92904423T ES2114931T3 ES 2114931 T3 ES2114931 T3 ES 2114931T3 ES 92904423 T ES92904423 T ES 92904423T ES 92904423 T ES92904423 T ES 92904423T ES 2114931 T3 ES2114931 T3 ES 2114931T3
Authority
ES
Spain
Prior art keywords
hydrogen
straight chain
branched hydrocarbon
steroid esters
new steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92904423T
Other languages
English (en)
Spanish (es)
Inventor
Bengt Axelsson
Ralph Brattsand
Leif Kallstrom
N Arne Thal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2114931T3 publication Critical patent/ES2114931T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES92904423T 1991-02-04 1992-01-29 Nuevos esteres esteroidales. Expired - Lifetime ES2114931T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100342A SE9100342D0 (sv) 1991-02-04 1991-02-04 Novel steroid esters

Publications (1)

Publication Number Publication Date
ES2114931T3 true ES2114931T3 (es) 1998-06-16

Family

ID=20381807

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92904423T Expired - Lifetime ES2114931T3 (es) 1991-02-04 1992-01-29 Nuevos esteres esteroidales.

Country Status (37)

Country Link
US (1) US5614514A (2)
EP (1) EP0572451B1 (2)
JP (1) JP2947933B2 (2)
KR (1) KR100205835B1 (2)
CN (3) CN1039329C (2)
AP (1) AP365A (2)
AT (1) ATE164589T1 (2)
BG (1) BG61816B1 (2)
CA (1) CA2100453A1 (2)
CZ (1) CZ282057B6 (2)
DE (1) DE69224982T2 (2)
DK (1) DK0572451T3 (2)
DZ (1) DZ1554A1 (2)
EE (1) EE03110B1 (2)
ES (1) ES2114931T3 (2)
FI (1) FI933451A0 (2)
HU (1) HU221168B1 (2)
IE (1) IE920167A1 (2)
IL (1) IL100542A (2)
IS (1) IS1653B (2)
MA (1) MA22407A1 (2)
MX (1) MX9200374A (2)
MY (1) MY111502A (2)
NO (1) NO304074B1 (2)
NZ (1) NZ241211A (2)
PL (1) PL170383B1 (2)
PT (1) PT100087B (2)
RO (1) RO111272B1 (2)
RU (1) RU2112775C1 (2)
SE (1) SE9100342D0 (2)
SK (1) SK281802B6 (2)
TN (1) TNSN92008A1 (2)
TW (1) TW287166B (2)
UA (1) UA43825C2 (2)
WO (1) WO1992013873A1 (2)
YU (1) YU48893B (2)
ZA (1) ZA92234B (2)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
CA2152374A1 (en) * 1993-01-08 1994-07-21 Ralph Lennart Brattsand Novel colon- or ileum-specific steroid derivatives
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
GB9923076D0 (en) 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
MXPA01012169A (es) 1999-05-27 2002-06-21 Euro Celtique Sa Preparaciones para la aplicacion de agentes anti-infecciosos y/o anti-lamatorios para partes externas o internas del cuerpo humano o animal en la remodelacion funcional y cosmetica y tratamientos para reparacion de tejidos.
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
EP1453743B1 (en) * 2001-11-17 2008-07-23 Aventis Pharma Limited Pharmaceutical product and method with an adsorbent
US20050009798A1 (en) 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
WO2003070745A2 (en) 2002-02-20 2003-08-28 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids
RU2330858C2 (ru) 2002-07-08 2008-08-10 Глаксомитклайн Истраживацки Центар Загреб Д.О.О. Новые соединения, составы и способы лечения воспалительных заболеваний и состояний
US7157433B2 (en) 2002-07-08 2007-01-02 Glaxosmithkline Istrazivacki Centar Zagreb Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules
US20040157810A1 (en) * 2002-08-23 2004-08-12 Teicher Martin H. Corticosteroid conjugates and uses thereof
WO2004033478A2 (en) * 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
WO2005016352A1 (en) * 2003-08-05 2005-02-24 Sepracor Inc. AMINO ACID AND PEPTIDE-MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH ß2 ADRENERGIC AGONISTS
RU2253453C1 (ru) * 2004-03-15 2005-06-10 Общество с ограниченной ответственностью "ЮНАЛ" Противовоспалительная и антиаллергическая композиция
ES2337915T3 (es) 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
RU2337358C1 (ru) * 2007-04-03 2008-10-27 Некоммерческая организация Учреждение "ПРОГРЕССИВНЫЕ МЕДИЦИНСКИЕ ИССЛЕДОВАНИЯ" Способ спектрофотометрического определения концентрации липосомально инкапсулированных фармацевтических препаратов
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US8737506B1 (en) 2010-12-29 2014-05-27 Sprint Communications Company L.P. Determination of transmit diversity transmission delays
US8437713B1 (en) 2011-02-16 2013-05-07 Sprint Communications Company L.P. Wireless transmit diversity control by location of a wireless communication device
US8565686B2 (en) 2011-06-30 2013-10-22 Sprint Communications Company L.P. Power status multipath search window sizing for wireless communications
DK2797601T3 (en) 2012-02-10 2018-06-14 Taiwan Liposome Co Ltd PHARMACEUTICAL COMPOSITIONS FOR REDUCING COMPLICATIONS BY Ocular steroid
JP5965187B2 (ja) * 2012-03-30 2016-08-03 小林製薬株式会社 油性軟膏剤
CN109985048B (zh) * 2017-12-29 2021-06-29 广州市赛普特医药科技股份有限公司 2β,3α,5α-三羟基雄甾-6-酮用于炎症反应的治疗

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3197469A (en) * 1958-08-06 1965-07-27 Pharmaceutical Res Products In 16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3357974A (en) * 1965-12-28 1967-12-12 Merck & Co Inc Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
SE378109B (2) * 1972-05-19 1975-08-18 Bofors Ab
US3796701A (en) * 1973-02-26 1974-03-12 Squibb & Sons Inc 5alpha,9-oxazino steroids and 9-carboxamido steroids
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4304727A (en) * 1980-12-05 1981-12-08 The Upjohn Company 9α-Debromination
JPS58176485A (ja) * 1982-04-08 1983-10-15 Nippon Denso Co Ltd 可変容量圧縮機
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
JPS6067496A (ja) * 1983-09-26 1985-04-17 Ota Seiyaku Kk フルオシノロン１６，１７−アセトニド２１−ブチレ−トおよびその製造法
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters

Also Published As

Publication number Publication date
IE920167A1 (en) 1992-08-12
CZ282057B6 (cs) 1997-05-14
FI933451A7 (fi) 1993-08-03
IS3809A (is) 1992-08-05
PT100087B (pt) 1999-09-30
TW287166B (2) 1996-10-01
YU6492A (sh) 1994-12-28
IL100542A0 (en) 1992-09-06
EP0572451B1 (en) 1998-04-01
CA2100453A1 (en) 1992-08-05
FI933451L (fi) 1993-08-03
CN1076607C (zh) 2001-12-26
DK0572451T3 (da) 1998-10-19
SK281802B6 (sk) 2001-08-06
NZ241211A (en) 1993-08-26
BG98011A (bg) 1994-04-29
EE03110B1 (et) 1998-08-17
CN1076606C (zh) 2001-12-26
CN1158726A (zh) 1997-09-10
IL100542A (en) 1997-02-18
SE9100342D0 (sv) 1991-02-04
DE69224982D1 (de) 1998-05-07
NO304074B1 (no) 1998-10-19
YU48893B (sh) 2002-10-18
ATE164589T1 (de) 1998-04-15
WO1992013873A1 (en) 1992-08-20
AP9200354A0 (en) 1992-01-31
JPH06505233A (ja) 1994-06-16
DE69224982T2 (de) 1998-07-30
RU2112775C1 (ru) 1998-06-10
KR100205835B1 (ko) 1999-07-01
SK79793A3 (en) 1994-03-09
UA43825C2 (uk) 2002-01-15
AU1235892A (en) 1992-09-07
ZA92234B (en) 1992-10-28
MY111502A (en) 2000-07-31
CZ149593A3 (en) 1994-03-16
RO111272B1 (ro) 1996-08-30
HU9302243D0 (en) 1993-10-28
NO932762D0 (no) 1993-08-02
HK1004335A1 (en) 1998-11-20
TNSN92008A1 (fr) 1993-06-08
FI933451A0 (fi) 1993-08-03
IS1653B (is) 1997-06-20
HUT64972A (en) 1994-03-28
JP2947933B2 (ja) 1999-09-13
HU221168B1 (en) 2002-08-28
MX9200374A (es) 1992-08-01
CN1064078A (zh) 1992-09-02
NO932762L (no) 1993-08-02
EP0572451A1 (en) 1993-12-08
US5614514A (en) 1997-03-25
PL170383B1 (pl) 1996-12-31
BG61816B1 (bg) 1998-06-30
CN1039329C (zh) 1998-07-29
AP365A (en) 1994-10-21
DZ1554A1 (fr) 2002-02-17
AU661472B2 (en) 1995-07-27
CN1155418A (zh) 1997-07-30
PT100087A (pt) 1993-05-31
MA22407A1 (fr) 1992-10-01

Similar Documents

Publication Publication Date Title
ES2114931T3 (es) Nuevos esteres esteroidales.
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
AR015157A1 (es) DERIVADOS DEL ÁCIDO 5-ALQUIL-2-ARILAMINOFENILÁCETICO, COMPOSICIoN FARMACÉUTICA QUE LO COMPRENDE, SU USO EN LA MANUFACTURA DE UN MEDICAMENTO Y MÉTODO DE PREPARACIoN DEL MISMO
MX9307779A (es) Compuestos benzoicos fundidos.
AR038433A2 (es) Derivados 2-alquil-2-desoxo de parahercuamida y marcfortina
ES2149350T3 (es) Compuestos y liposomas farmaceuticamente activos y metodos para su utilizacion.
ITMI921601A1 (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2158284T3 (es) Metil-fenil-oxazolidinonas quirales.
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
ES2157314T3 (es) Derivados triciclicos y su uso en productos farmaceuticos.
MX9302957A (es) Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
DK0406119T3 (da) Hidtil ukendte peptidderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
ES2078507T3 (es) Medicinas y derivados de sulfonanilida.
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
MX9301404A (es) Derivados de 2-oxoquinolina, procedimiento para su preparacion, preparado farmaceutico que los contiene y procedimiento para la obtencion de tal preparado farmaceutico.
DK0649405T3 (da) 22-en-25-oxa-derivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt anvendelse af sådanne præparater som lægemidler.
ES2039292T3 (es) Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ES2107806T3 (es) Nuevos esteroides.
ATE74924T1 (de) N-(vinblastinoyl-23)-derivate von 1aminomethylposphons|ure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
ES2060592T3 (es) Un tioester y su uso en la preparacion de composiciones farmaceuticas para el tratamiento de los sindromes de isquemia y reperfusion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 572451

Country of ref document: ES